A PHASE 3, MULTI-CENTER, MULTI-NATIONAL, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED INDUCTION AND MAINTENANCE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CC-93538 IN ADULT AND ADOLESCENT SUBJECTS WITH EOSINOPHILIC ESOPHAGITIS
Clinical Trial Grant
Administered By
Medicine, Gastroenterology
Awarded By
Celgene Corporation
Start Date
December 6, 2021
End Date
November 9, 2025
Administered By
Medicine, Gastroenterology
Awarded By
Celgene Corporation
Start Date
December 6, 2021
End Date
November 9, 2025